key: cord-0721327-9kr34sg1
authors: Liu, Li; Hong, Xiuqin; Su, Xin; Chen, Haiou; Zhang, Dongcui; Tang, Shigang; Chen, Liang; Zhu, Baining; Li, Xiaosong; Shi, Yi
title: sOptimizing screening strategies for coronavirus disease 2019: A study from Middle China
date: 2020-05-14
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2020.05.003
sha: 3ed3832f47d89c165a8d081f4ca80e2a31e058ad
doc_id: 721327
cord_uid: 9kr34sg1

Abstract Background Coronavirus disease 2019 (COVID-19) has been highly epidemic in China since January 2020. Rapid detection of the causative agent, severe acute respiratory coronavirus-2 (SARS-CoV-2), is very important due to its high rate of infectivity. This study aimed to clarify the epidemiology and clinical characteristics of COVID-19 outside of Hubei province, China, and to optimize screening strategies for COVID-19 in attempts to contain spread of the virus. Methods This retrospective study included all confirmed cases of COVID-19 in Hunan Provincial People's Hospital (Changsha, China) between January 22 and February 15, 2020. All cases were detected using a real-time reverse transcription polymerase chain reaction assay. The epidemiology and clinical characteristic of these cases were investigated according to outcome in attempts to optimize screening strategies for COVID-19. Results There were 24 confirmed cases of COVID-19 in the fever outpatient department of Hunan Provincial People's Hospital. Three patients were asymptomatic, and 3 exhibited mild and 3 moderate disease. There was a family cluster phenomenon. Conclusion Individuals with COVID-19 can be asymptomatic or exhibit mild manifestations of disease. Close monitoring and an optimized screening strategy for COVID-19 could help deter spread of the virus.

Reports of infections caused by a novel coronavirus, severe acute respiratory coronavirus-2 64 (SARS-CoV-2), began to emerge from Wuhan, Hubei province, China, shortly after December provinces of China [10, 11] . Initially, researchers found that SARS-CoV-2 infection caused 74 severe acute respiratory symptoms, and some patients developed expiratory dyspnea such as 75 acute respiratory distress syndrome, acute respiratory failure, and other organ complications 76 including sepsis and sepsis shock approximately 1 week after infection [9, 12, 13 ]. However, it 77 was found that many patients experienced only symptoms and many others who exhibited no 78 symptoms [10] . 79 COVID-19 is characterized by rapid transmission and atypical clinical symptoms. It is easy 80 to miss diagnosis and/or to misdiagnose. To contain spread of the epidemic, it is very important 81 to screen for patients with especially (Table   120 1). 121 Among all confirmed cases in the fever outpatient department, 19 (79.17%) had fever, 6 122 (25%) had dry cough, 6 (25%) had fatigue, 4 (16.67%) had dizziness; other symptoms included 123 loss of appetite, muscle ache, headache, and shortness of breath (Table 2 ). In the fever 124 outpatient department, leukocyte, lymphocyte, and platelet counts were in the normal range in 125 most patients (Table 2) . Three (12.5%) patients were asymptomatic, 3 exhibited mild 126 symptoms, most of them were of medium severity. No patients experienced organ damage 127 from sepsis, septic shock, or respiratory failure. There was a family cluster phenomenon (Table   128 2). No patients were co-infected with other viruses. PCT levels and ESR were tested, most of was a third-generation case. At the same time, there was a family cluster phenomenon [15, 20] . 153 There were four families in which most members were infected accounting for one-half of the 154 total cases. 155 We found that 12.5% patients exhibited asymptomatic infection. They were suspected based 156 on epidemiological history and confirmed by RT-PCR; as such, they were infectious sources. 

A novel coronavirus from 230 patients with pneumonia in China

Genomic characterization and epidemiology of 233 2019 novel coronavirus: implications for virus origins and receptor Binding

WHO. Novel coronavirus-Thailand (ex-China)

Clinical features of patients infected with 2019 novel 265 coronavirus in Wuhan

Clinical characteristics of 138 268 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Importation 273 and human-to-human transmission of a novel coronavirus in Vietnam

First case of 276 2019 novel coronavirus in the United States

SARS and MERS: recent insights 283 into emerging coronaviruses

A familial cluster of pneumonia 287 associated with the 2019 novel coronavirus indicating person-to-person transmission: a 288 study of a family cluster

Alert for non-respiratory symptoms 291 of coronavirus disease 2019 (COVID-19) patients in epidemic period: A case report of 292 familial cluster with three asymptomatic COVID-19 patients

Correlation of chest ct and rt-pcr 295 testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases

Evaluation of 298 nucleocapsid and spike protein-based ELISAs for detecting antibodies against 299 SARS-CoV-2

Chart 1 Optimizing screening strategies for COVID-19